CD274 and neoplasm: Their activity is based on the reversion of the immunosuppressive effect caused by the expression and interaction of immune checkpoints as Programmed cell death 1 receptor (PD-1) and its ligands (PD-L1 or PD-L2), after continuous stimulation in the tumour microenvironment.